Corporate insider profile
Gary K. Lee Insider Trades
Gary K. Lee has reported no open-market purchases on SEC Form 4 and is a net seller of $29,035 across 1 company. The most recent open-market transaction was reported on Nov 10, 2026. Source: SEC Form 4 filings.
Latest reported as Chief Scientific Officer of Lyell Immunopharma, Inc. (LYEL).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$29,034.89
- Latest transaction
- Nov 10, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Gary K. Lee insider trading FAQ
- Is Gary K. Lee buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Gary K. Lee is a net seller of $29,035, with no open-market purchases reported. The latest transaction was reported on Nov 10, 2026.
- Which companies does Gary K. Lee report insider trades for?
- Gary K. Lee has reported open-market trades in Lyell Immunopharma, Inc. (LYEL). The latest SEC-reported relationship is Chief Scientific Officer of Lyell Immunopharma, Inc. (LYEL).
- Where does Gary K. Lee's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1907345, and refreshes this page daily.
